MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma.
Saved in:
| Title: | MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma. |
|---|---|
| Authors: | Friker LL; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. lea.friker@ukbonn.de.; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany. lea.friker@ukbonn.de., Perwein T; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.; Styrian Children's Cancer Research, Research Unit for Cancer and Inborn Errors of the Blood and Immunity in Children, Medical University of Graz, Graz, Austria., Waha A; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Dörner E; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Klein R; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Blattner-Johnson M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Layer JP; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany., Sturm D; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Nussbaumer G; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria., Kwiecien R; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Aretz S; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Hennewig U; Department of Pediatric Hematology and Oncology, University Hospital Giessen and Marburg, Giessen, Germany., Rohde M; Department of Pediatric Hematology and Oncology, University Hospital Giessen and Marburg, Giessen, Germany., Karow A; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen, Erlangen, Germany., Bluemcke I; Institute of Neuropathology, University Hospital Erlangen, Erlangen, Germany., Schmitz AK; Department of Pediatrics, Asklepios Kinderklinik Sankt Augustin, Sankt Augustin, Germany., Reinhard H; Department of Pediatrics, Asklepios Kinderklinik Sankt Augustin, Sankt Augustin, Germany., Hernáiz Driever P; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, German HIT-LOGGIC-Registry for pLGG in Children and Adolescents, Berlin, Germany., Wendt S; Department of Pediatric Oncology and Hematology, University Hospital Leipzig, Leipzig, Germany., Weiser A; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Guerreiro Stücklin AS; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.; Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Gerber NU; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland., von Bueren AO; Department of Pediatrics, Gynecology and Obstetrics, Division of Pediatric Hematology and Oncology, Geneva University Hospital, Geneva, Switzerland.; Department of Pediatrics, Gynecology and Obstetrics, CANSEARCH Research Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Khurana C; Department of Pediatric Hematology and Oncology, Children's Center Bethel, University Hospital Ostwestfalen-Lippe, Bielefeld, Germany., Jorch N; Department of Pediatric Hematology and Oncology, Children's Center Bethel, University Hospital Ostwestfalen-Lippe, Bielefeld, Germany., Wiese M; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., Eyrich M; University Children's Hospital, University Hospital Würzburg, Würzburg, Germany., Karremann M; Department of Pediatric and Adolescent Medicine and Mannheim Cancer Center (MCC), University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Herrlinger U; Department of Neurooncology, Center for Neurology and CIO ABCD, University Hospital Bonn, Bonn, Germany., Hölzel M; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany., Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Hoffmann M; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Pietsch T; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Gielen GH; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany., Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany. |
| Source: | Acta neuropathologica [Acta Neuropathol] 2025 Feb 02; Vol. 149 (1), pp. 11. Date of Electronic Publication: 2025 Feb 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0533 |
|---|---|
| DOI: | 10.1007/s00401-025-02846-x |
